In this consideration, our study highlights the role of MMP-2 in the regulation of mitochondrial injury mediated by TSPO and VDAC1 in the onset of DCM, thus contributing to the identification of novel potential targets of cardioprotective therapeutic interventions under hyperglycaemia. The gene discussed is MMP2; the disease is familial dilated cardiomyopathy.